Clinical Trial Detail

NCT ID NCT01087554
Title Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Temsirolimus

Everolimus

Sirolimus

Vorinostat

Age Groups: child senior adult

No variant requirements are available.